ArticleCureus2025
Cytopathology of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ThoracicJournal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is an aggressive tumor with a dismal prognosis, most commonly involving the mediastinum and lungs. The diagnosis of SMARCA4-UT is still challenging, both clinically and pathologically, due to its non-specific clinical findings, a broad list of differential diagnoses, and rarity of cases reported in the literature, especially in terms of cytopathology. Most patients present at an advanced stage of disease at the time of diagnosis, and fine needle aspiration (FNA) cytology specimens and/or core biopsies are often the only diagnostic material available. SMARCA4-UT tumors are strongly associated with a smoking history; however, approximately 10% of the patients are never smokers. We report a case of a 78-year-old male with a remote minimal smoking history who presented with a large mediastinal mass and hilar lymphadenopathy. FNA of the mass demonstrated a moderately cellular aspirate with two populations of loosely cohesive malignant cells in a background of necro-inflammatory debris and bare nuclei. The majority of malignant cells showed enlarged nuclei with prominent nucleoli and scant cytoplasm, with a few malignant cells showing rhabdoid features. Immunohistochemical staining of the cell block showed the malignant cells were patchy positive for INSM-1 and PAX-8; however, negative for keratin markers, TTF-1, Napsin A, and p40. SMARCA4-UT was diagnosed with the loss of SMARCA4 (BRG1) expression in the tumor cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.